✨ 17 results found - Searched 21219 records in 5ms.
Tesis
Analisis Potensi Interaksi Obat Pada Tatalaksana Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut di RS Kanker Dharmais Tahun 2023
2024 | BY Anggi Gayatri - Purwantyastuti Ascobat - Noorwati Soetandyo - Yolanda Safitri- Analysis of Potential Drug Interactions in the Management of Non-Small Cell Carcinoma Lung Cancer (NSCLC) Advanced Stage at Dharmais Cancer Hospital in 2023.
- Nomor Panggil T24404fk
Tesis
Proporsi asam deoksiribonukleat cytomegalovirus dari jaringan kanker paru karsinoma bukan sel kecil di RSUP Persahabatan
2024 | BY Ibrahim Nur Insan Putra Dharmawan - Jamal Zaini - Irandi Putra Pratomo - Eylin- Proportion of cytomegalovirus deoxyribonucleic acid from nonsmall cell lung cancer at Persahabatan Hospital.
- Nomor Panggil T24257fk
Skripsi
Hasil Pemeriksaan Immuno-Chromatography Test (ICT) LD Bio Aspergillus dibandingkan dengan IgG spesifik Aspergillus pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) di RSUP Persahabatan
2020 | BY Asiyah Taqiyya Fakhrur Razi - Jamal Zaini- Comparison of Immuno-Chromatography Test (ICT) LD Bio Aspergillus with Aspergillus-specific lgG in Non-Small Cell Lung Cancer (NSCLC) Patients at Persahabatan General Hospital.
- Nomor Panggil S20164fk
Skripsi
Korelasi klinis dan hasil kultur jamur Aspergillus yang diisolasi dari sputum induksi pada kanker paru karsinoma bukan sel kecil
2020 | BY Zahra Annisa - Jamal Zaini- Clinical correlation and culture results of Aspergillus fungi isolated from sputum induction of non-small cell lung carcinoma patients.
- Nomor Panggil S20124fk
Tesis
Status Fungsional, Rasio Limfosit Monosit dan Rasio Trombosit Limfosit sebagai Faktor Prognosis Kesintasan Satu Tahun Pasien Lanjut Usia dengan Kanker Paru Karsinoma Bukan Sel Kecil Stadium IIIB-IV
2024 | BY Ratna Nurhayati - Aulia Rizka - Noorwati Sutandyo - Cleopas Martin Rumende- Functional Status, Lymphocyte to Monocyte Ratio and Platelet to Lymphocyte Ratio as a Prognostic Factor of 1-year Survival in Elderly with Non-Small Cell Lung Stage IIIB-IV.
- Nomor Panggil T24053fk
Tesis
Proporsi gambaran penyakit paru interstisial pada pasien kanker paru karsinoma bukan sel kecil dengan terapi epidermal growth factor receptor tyrosine kinase inhibitor di RSUP Persahabatan
2023 | BY Marscha Iradyta Ais - Sita Laksmi Andarini - Dianiati Kusumo Sutoyo - Maryastuti- The proportion of interstial lung disease features in patients with non small cell lung cancer treated with epidermal growth factor receptors tyrosine kinase inhibitor at Persahabatan Hospital.
- Nomor Panggil T23187fk
Tesis
Hubungan rasio trombosit limfosit dan rasio neutrofil limfosit darah dengan respons klinis pada pasien kanker paru karsinoma bukan sel kecil stage lanjut yang mendapat kemoterapi
2022 | BY Eliasta Simpar Sitepu - Dianiati Kusumo Sutoyo - Andika Chandra Putra - Jamal Zaini- Relationship between serum platelets to lymphocytes ratio and serum neutrophils to lymphocytes ratio with clinical response in advanced stage non-small cell lung cancer patients receiving chemotherapy.
- Nomor Panggil T22442fk
Tesis
Perbandingan Efikasi Dan Toksisitas Hematologi Kemoterapi Lini I Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Jenis Karsinoma Sel Skuamosa (KSS) Dengan Adenokarsinoma EGFR wild typeDi RSUP Persahabatan
2018 | BY Enita Mayasari - Elisna Syahruddin - Andika Chandra Putra- The Efficacy and Hematological Toxicity of First-line Chemotherapy of Non-small Cell Lung Cancer (NSCLC) Patients Treated at Persahabatan Hospital Jakarta, Indonesia .
- Nomor Panggil T18483fk
Tesis
Perubahan indeks massa tubuh, persentase otot rangka dan kadar albumin pada pasien kanker paru karsinoma bukan sel kecil ( KPKBSK ) sebelum dan setelah kemoterapi
2014 | BY Yenni Sari Siregar - Elisna Syahruddin - Wahju Aniwidyaningsih- Body mass index ( BMI), percentage of scletal muscle and albumin in non small cell lung cancer ( NSCLC) patiens before and after chemotherapy.
- Nomor Panggil T14583fk
Tesis
Profil Efikasi dan Toksisitas Terapi Target Baru Golongan Epidermal Factor Receptor-Tyrosine Kinase Inhibitor (EGFRTKi)Pada Pasien Kanker Paru Karsinoma Bukan Sel Kecil Non Skuamosa Dengan Mutasi EGFR Positif Dibandingkan Dengan Kemoradioterapi Pada EGFR Wild Type
2014 | BY Sita Laksmi Andarini - Wiendo Syah Putra Yahya - Achmad Hudoyo - Ahmad Utomo- Profile of Efficacy and Toxicity The New Targeted Therapy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKi) in Non Small Cell Lung Cancer Non-Squamous With Mutated EGFR Compared With Chemoradiotherapy In Wild Type
- Nomor Panggil T14533fk